JP Patent

JP6101010B2 — 抗生物質の使用に関連する疾患の治療

Assigned to Merck Sharp and Dohme LLC · Expires 2017-03-22 · 9y expired

What this patent protects

Patent listed against Dificid.

Drugs covered by this patent

Patent Metadata

Patent number
JP6101010B2
Jurisdiction
JP
Classification
—
Expires
2017-03-22
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.